Martin Lefkowitz
Brigham and Women's Hospital(US)Harvard University(US)Novartis (United States)(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, Blood Pressure and Hypertension Studies, Potassium and Related Disorders
Most-Cited Works
- → Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure(2014)6,700 cited
- → Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction(2019)2,275 cited
- → Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure(2014)661 cited
- → Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study(2010)589 cited
- → Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure(2019)527 cited
- → Dual Angiotensin Receptor and Neprilysin Inhibition as an Alternative to Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale for and Design of the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure Trial (PARADIGM-HF)